Skip to content

Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum

Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01771380
Enrollment
78
Registered
2013-01-18
Start date
2013-02-28
Completion date
2015-08-31
Last updated
2015-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Glucose Tolerance

Brief summary

In the circulation 25-hydroxyvitaminD (25(OH)D) is bound to the vitamin D binding protein (DBP) and albumin. According to the free hormone hypothesis, it is, however, the free fraction that is biologically active. Polymorphisms in DBP are related to the serum level of 25(OH)D. As these polymorphisms may also affect the binding affinities for 25(OH)D, the total serum 25(OH)D may not necessary reflect the free fraction. To test this hypothesis, we will calculate the free fraction of 25(OH)D by correction for DBP and albumin content, and also measure free 25(OH)D from equilibrium dialysis and ultra filtration. Furthermore, we will relate total serum 25(OH)D as well as the free and biologically active (free- albumin-bound) 25(OH)D to the well established vitamin D effect marker serum parathyroid hormone as well as to the RNA expression in peripheral blood to evaluate the biological importance of the free versus the total fraction of 25(OH)D. We will invite 300 subjects from an ongoing vitamin D supplementation study to participate in the study which will be one visit only and include collection of blood samples.

Interventions

None listed

Sponsors

University of Tromso
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Impaired glucose tolerance * living in the Tromsø area

Exclusion criteria

* pregnancy * serious illness

Design outcomes

Primary

MeasureTime frame
Free fraction of 25(OH)D1 day

Secondary

MeasureTime frame
DBP polymorphisms1 day

Other

MeasureTime frame
RNA expression in peripheral blood1 day

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026